Ameta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage

被引:0
|
作者
Coleman, C. [1 ]
Karadenes, A. [1 ]
Cassano, C. [1 ]
Baker, W. L. [1 ]
机构
[1] Univ Connecticut, Storrs, CT USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] High-dose versus low-dose 4-factor prothrombin complex concentrate for factor Xa inhibitor reversal in intracranial hemorrhage
    Davis, Spencer D.
    Chauv, Stephanie
    Hickman, Abby W.
    Collingridge, Dave S.
    Kjerengtroen, Sara
    Fontaine, Gabriel, V
    THROMBOSIS RESEARCH, 2021, 208 : 112 - 116
  • [2] Effect of low-versus high-dose 4-factor prothrombin complex concentrate in factor Xa inhibitor-associated bleeding: A qualitative systematic review
    Phillips, Anna
    Bradley, Colby
    Cash, Julie
    Sangiovanni, Ryan
    Wingerson, Charles
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (11) : e274 - e282
  • [3] PROTHROMBIN COMPLEX CONCENTRATE IN FACTOR XA INHIBITOR-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Priano, James
    Vilar, Jason
    Quevedo, Darla
    Rzasa, Kaitlin
    CRITICAL CARE MEDICINE, 2020, 48
  • [4] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Mary Hormese
    Alex Littler
    Brian Doane
    Nicole Glowacki
    Ann Khimani
    Nicole Vivacqua
    Karina Rudenberg
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 828 - 835
  • [5] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Hormese, Mary
    Littler, Alex
    Doane, Brian
    Glowacki, Nicole
    Khimani, Ann
    Vivacqua, Nicole
    Rudenberg, Karina
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 828 - 835
  • [6] Effectiveness of high- versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated intracranial hemorrhage
    Baker, W.
    Cassano, C.
    Karadenes, A.
    Coleman, C. I.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [7] EVALUATION OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE DOSING FOR FACTOR XA INHIBITOR REVERSAL
    Craven, Cody
    Sbertoli, Robert
    Ramiro, Joanna
    Emery, Darrick
    Braun, James
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 436 - 436
  • [8] Low-dose versus standard-dose four-factor prothrombin complex concentrate for factor-Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage
    Cascone, Ava E.
    Daley, Mitchell J.
    Pan, Neil
    Padilla-Tolentino, Eimeira
    Milling, Truman J.
    PHARMACOTHERAPY, 2021, 41 (06): : 501 - 507
  • [9] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR FACTOR XA INHIBITOR-ASSOCIATED HEMORRHAGE
    Kaplan, Justin
    Procopio, Gabrielle
    Perez, Javier Martin
    Minova, Ljubica
    Bicking, Keri
    Jain, Ruchi
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 259 - 259
  • [10] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261